Over 2,700 testosterone gel lawsuits are pending in the US. According to a Forbes article from late October 2015, testosterone lawsuits numbered around 2,000 in August 2015. In the ensuing months, even more men who suffered serious testosterone side effects stepped forward, bringing the total near 3,000.
A legal representative commented in the Forbes article that the lawsuits are “not quite to the halfway point in terms of the number of suits we’re going to see.”
Testosterone lawsuits are consolidated in a multidistrict litigation (MDL) in Chicago. The MDL cites 7 companies that make testosterone products.
The US District Court Judge managing the MDL, Judge Matthew Kennelly, is moving pretrial proceedings along at an efficient pace. In late 2016, the court will begin the bellwether trial process; at this time, rulings will be made on bellwether testosterone lawsuits that both parties carefully selected as representative of a majority of the MDL lawsuits.
This first round of bellwether cases scheduled for 2016 involves AbbVie and their testosterone product, AndroGel.
These AndroGel lawsuits allege that AbbVie’s testosterone product caused blood clots, heart attacks, and strokes. These lawsuits also argue that AbbVie’s AndroGel marketing campaigns misled them to believe the product as safe.
According to the Forbes article cited above, AndroGel sales plummeted as testosterone lawsuits rose. AndroGel sales dropped by 32% in the first 6 months of 2015.
Carey Danis & Lowe AndroGel lawyers represent men just like you who have been injured by testosterone gel, including Abbvie’s AndroGel. Our team of experienced testosterone lawyers are investigating cases, and encourage you to explore your legal options with us today.
For a free case evaluation, call us toll free at 800.721.2519.
You can also reach us online by completing a confidential personal injury claim form.References: Pharmaceutical litigation, Testosterone